Altimmune

Nasdaq: ALT · SEC EDGAR filings

Results on file1
Average 24h move+1.35%across 1 result with a complete 24h price
1 resultAltimmune
Met endpoint

Pemvidutide

Phase 2 n=100 Alcohol Use Disorder (AUD)

Altimmune ALT

24h stock move +1.35%

For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.